AVENUE SOLUTIONS for CUBIST PHARMACEUTICALS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 1734 / H.R. 2182, Generating Antiobiotic Incentives Now Act (GAIN Act) - incentives for development of products to treat antibiotic-resistant infections; S. 3187, Food and Drug Administration Safety and Innovation Act - incentives for development of products to treat antibiotic-resistant infections; H.R. 5651, Food and Drug Administration Reform Act of 2012 - incentives for development of products to treat antibiotic-resistant infections
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Pharmacy PHA
S. 1734 / H.R. 2182, Generating Antiobiotic Incentives Now Act (GAIN Act) - incentives for development of products to treat antibiotic-resistant infections; S. 3187, Food and Drug Administration Safety and Innovation Act - incentives for development of products to treat antibiotic-resistant infections; H.R. 5651, Food and Drug Administration Reform Act of 2012 - incentives for development of products to treat antibiotic-resistant infections
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Budget/Appropriations BUD
Impact of sequestration on FDA user fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.